Bone Biologics Corp
BBLG· Nasdaq
BBLGBone Biologics Corp
Filed Nov 16, 2018 · 10-Q · 47 days after period end · 0001493152-18-016378
| Metric | Q3 2018 | Q3 2017 | Q3 2016 | Q3 2015 |
|---|---|---|---|---|
| Net Income | -$241.74K | -$2.38M | -$4.22M | -$3.36M |
| EPS Diluted | -$0.03 | -$0.61 | -$0.11 | -$0.11 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bone Biologics Corp · CIK 1419554 · Engraved from SEC EDGAR
ended Sep 30, 2018 · filed Nov 16, 2018 · 47 d after period end
